Longboard Pharmaceuticals Inc Investor Day Transcript
Everyone, welcome to the Longboard Pharmaceuticals 2023 investor and analyst event. I'm Kevin Lind, President and CEO of Longboard. It's very nice to see all of you here in person, and I want to extend a welcome to all of the people online as well.
We're very excited about this event because it's our first official in-person investor and analyst day that we've hosted as a company and we're looking forward to framing what we believe is an extraordinary opportunity for LP352, a best-in-class 5-HT2C superagonist currently being evaluated in the PACIFIC study with top line data expected in January -- a major catalyst for the company and what we've been working on since our inception in 2020.
I'm enthusiastic to kick off the event, but before we begin, I'd like to remind you that we will be making forward-looking statements. These forward-looking statements include substantial risks and uncertainties that could cause material changes. Please see our full risk factors described in the company's reports filed with the SEC.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
